US trade rep to talk with WTO about IP and Covid-19 vaccines – STAT
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online calls and deadlines has predictably returned. But what can you do? Somehow, the world keeps spinning, despite conspiracy theories. So to give it a little push in the right direction, we are brewing cups of stimulation. Our choice today is cinnamon mocha, which we like to think is a sophisticated favorite. Well, whatever. Meanwhile, here are a few tidbits for you to consume. We hope your day goes well, and, as always, please do stay in touch. …
Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, plans to run for a second five-year term as the head of the agency, according to STAT, setting up a referendum on the WHO’s handling of the Covid-19 pandemic under his leadership. It is unclear at this point whether others will emerge to challenge the 56-year-old from Ethiopia, who made history in 2017 when he became the first African elected to the WHO’s top job. WHO director-generals may only serve two five-year terms, and must be elected each time.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
What is it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
*** This article has been archived for your research. The original version from STAT can be found here ***
